In attendance

Members in attendance

• Director of Data Management and Transformation (Chair), NHS England
• Director of Digital Operations and Innovation, Chelsea and Westminster Hospital NHS Foundation Trust
• Director of Delivery, Palantir
• Data Governance and Assurance, NHS England Principal Accountant, NHS England
• Deputy Director, Product Development and Implementation, NHS England
• Regional Director of Digital Transformation – East of England, NHS England
• Deputy Director, Demand and Delivery, NHS England Chief Medical Officer, Kent Community Trust
• Regional Chief Operating Officer, Midlands, NHS England Director of UEC Delivery, NHS England
• Regional Director of Digital Transformation – Midlands, NHS England

Terms of Reference Members:

• FDP Senior Governance Secretariat Officer, NHS England
• FDP Corporate and Governance Compliance Manager, NHS England
• Portfolio Director, NHS England

In attendance (presenters/ad hoc):

• Deputy Director, Data Collection & Delivery, NHS England Senior Product Manager, Transformation, NHS England

Apologies

• Joint Chief Digital Officer, Nottingham & Nottinghamshire ICS, Derby & Derbyshire ICS
• Director of Data and Analytics, Deputy Chief Data and Analytics Officer, NHS England
• Head of Information Governance, FDP, NHS England
• Assistant Head of Communications, Transformation Directorate, NHS England
• Director (Data and Analytics), Transformation, NHS England Medical Productivity Director, NHS England
• Director of Advanced Analysis, Data and Analytics, NHS England
• Deputy Managing Director, North of England Commissioning Support Unit
• Director of Privacy, Transparency and Ethics, NHS England Programme Management Director, IQVIA
• Finance Partnering Senior Lead, NHS England
• National Medical Director for Secondary Care, Consultant Vascular and General Surgeon, NHS England
• Director of Transformation and Quality Improvement, University Hospitals of Northamptonshire
• Chief Technology Officer, North of England Commissiong Support Unit
• Senior Commercial Lead, NHS England
• Director of Delivery – National Cancer Programme, NHS England
• Executive Director, Strategy Change and In Hospital Services, NHS Supply Chain, NHS England
• Commercial Director, IQVIA

1. Welcome and introductions

The Chair opened the meeting. Apologies for absence were noted.

The minutes from the Programme Board meeting held on 25 September 2025 were reviewed and approved.

2. Declarations of interest

None.

3. Review of actions

The Board reviewed and noted the updated action log.

4. Decisions made

The Chair provided a summary of the recent Programme Delivery Group (PDG) decisions.

The Board noted updates regarding collaboration with the Department of Health and Social Care (DHSC) on FDP use, developments with Solution Exchange and successes relating to the recent FDP Build Day.

5. FDP highlight report

The Chair provided an overview of the FDP Highlight Report. The Board noted the current FDP workstream overview, Key Performance Indicators (KPIs) and risk profile.

157 Trusts had formally signed up to implement the FDP. A total of 125 Trusts were live / in delivery.

FDP continued to support 6 products in general availability, with a further 7 in advanced stages of their piloting processes and planned for being generally available before March 2026.

The Board received and noted the FDP Highlight report.

6. Benefits refresh

The Board received an update on the FDP Benefits Refresh, which outlined themes, aims, and actions focused on continuous improvement and analysis of FDP products.

The Board discussed the recently released NHS Medium Term Planning Framework. The Chair highlighted that the guidance encourages local organisations to adopt FDP as their primary platform, particularly when renewing product licences or procuring new solutions. The policy aims to maximise national investment, create a conformant data landscape, and support wider NHS ambitions around automation and AI.

7. FDP demand and delivery update

The Deputy Director of Demand and Delivery provided an update on the FDP Demand and Delivery (D&D) activity.

The Board received and noted the FDP Demand and Delivery update.

8. FDP product update

The Deputy of Product provided an update on national, local delivery and product progress.

The Board received and noted the Product Update.

9. Outpatients reimagined demo

The Deputy Director of Product presented an update and demo on the Outpatients Reimagined. This was an output from a 12 week sprint to reform outpatient pathways by integrating and repurposing existing products for improved coordination and value.

The pathway covered six stages: referral demand, waitlist management, diagnostics/testing, booking/scheduling, consultation, and follow up. The demo showcased a tool that channels referrals into FDP, enriching data and providing an intuitive triage interface for consultants.

The Board noted the demonstration.

10. NDIT overview up update

The NDIT team joined the meeting and provided an update on National Data Integration Tool (NDIT). NDIT is designed as a secure national safe haven for data collection, processing, and management on behalf of NHS England, including the handling of identifiable data. It sits between local FDP tenants, which focus on operational value, and the national FDP tenant, which manages pseudonymised data for analysis. This structure enables consistent data validation, linkage, and processing before pseudonymisation and analysis.

NDIT will consolidate approximately 30 legacy platforms, improving efficiency, scalability, security, and accessibility. It supports both automated data federation from local tenants and manual submissions via the new National Data Submission Portal.

The Board noted that NDIT fully adheres to Information Governance (IG) regulations, with identifiable data used only for direct care or statutory purposes, and all data is pseudonymised before broader analytical use.

The Board received and noted the NDIT update.

11. Any other business and close

The meeting concluded.

Date of next meeting: 4 December 2025
Completed by: Francis Ortega
Reviewed by: James Stanton
Confirmed by: Ayub Bhayat